Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-12

Clinical Trial Update: Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population [NA]

View source ↗

Summary

Completed clinical trial evaluating whether Lycium barbarum supplements affect the progression of senile cataract in a Hong Kong Chinese population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lycium barbarum supplement (Lycium barbarum)

Snippet

Sponsor: The Hong Kong Polytechnic University | Conditions: Lens Opacity | NA | Status: COMPLETED